Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T11388 | Target Info | |||
Target Name | Cathepsin K (CTSK) | ||||
Synonyms | Cathepsin X; Cathepsin O2; Cathepsin O; CTSO2; CTSO | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CTSK | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | amino{[4-({N-[(2S)-3-carboxy-2-hydroxypropanoyl]-L-leucyl}amino)butyl]amino}methaniminium | Ligand Info | |||
Canonical SMILES | CC(C)CC(C(=O)NCCCC[NH+]=C(N)N)NC(=O)C(CC(=O)O)O | ||||
InChI | 1S/C15H29N5O5/c1-9(2)7-10(20-14(25)11(21)8-12(22)23)13(24)18-5-3-4-6-19-15(16)17/h9-11,21H,3-8H2,1-2H3,(H,18,24)(H,20,25)(H,22,23)(H4,16,17,19)/p+1/t10-,11-/m0/s1 | ||||
InChIKey | QPQNJAXBPHVASB-QWRGUYRKSA-O | ||||
PubChem Compound ID | 5288145 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3C9E Crystal structure of the cathepsin K : chondroitin sulfate complex. | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [1] |
PDB Sequence |
APDSVDYRKK
10 GYVTPVKNQG20 QCGSCWAFSS30 VGALEGQLKK40 KTGKLLNLSP50 QNLVDCVSEN 60 DGCGGGYMTN70 AFQYVQKNRG80 IDSEDAYPYV90 GQEESCMYNP100 TGKAAKCRGY 110 REIPEGNEKA120 LKRAVARVGP130 VSVAIDASLT140 SFQFYSKGVY150 YDESCNSDNL 160 NHAVLAVGYG170 IQKGNKHWII180 KNSWGENWGN190 KGYILMARNK200 NNACGIANLA 210 SFPKM
|
|||||
|
GLN19
2.805
CYS22
4.047
GLY23
3.185
SER24
3.366
CYS25
1.815
TRP26
3.035
GLU59
2.924
ASN60
3.536
ASP61
3.848
GLY64
4.518
GLY65
3.248
|
|||||
PDB ID: 1ATK CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR E-64 | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [2] |
PDB Sequence |
APDSVDYRKK
10 GYVTPVKNQG20 QCGSCWAFSS30 VGALEGQLKK40 KTGKLLNLSP50 QNLVDCVSEN 60 DGCGGGYMTN70 AFQYVQKNRG80 IDSEDAYPYV90 GQEESCMYNP100 TGKAAKCRGY 110 REIPEGNEKA120 LKRAVARVGP130 VSVAIDASLT140 SFQFYSKGVY150 YDESCNSDNL 160 NHAVLAVGYG170 IQKGNKHWII180 KNSWGENWGN190 KGYILMARNK200 NNACGIANLA 210 SFPKM
|
|||||
|
GLN19
2.947
CYS22
4.065
GLY23
3.004
SER24
3.313
CYS25
1.797
TRP26
3.250
GLU59
2.602
ASN60
3.165
ASP61
2.886
GLY64
4.979
GLY65
3.392
|
|||||
PDB ID: 3H7D The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate | ||||||
Method | X-ray diffraction | Resolution | 2.24 Å | Mutation | Yes | [3] |
PDB Sequence |
APDSVDYREK
10 GYVTPVKNQG20 QCGSCWAFSS30 VGALEGQLKK40 KTGKLLNLSP50 QNLVDCVSEN 60 DGCGGGYMTN70 AFQYVQKNRG80 IDSEDAYPYV90 GQEESCMYNP100 TGKAAKCRGY 110 REIPEGNEKA120 LKRAVARVGP130 VSVAIDASLT140 SFQFYSKGVY150 YDESCNSDNL 160 NHAVLAVGYG170 ESKGNKHWII180 KNSWGENWGM190 GGYIKMARNK200 NNACGIANLA 210 SFPKM
|
|||||
|
GLN19
2.706
CYS22
3.870
GLY23
3.268
SER24
3.316
CYS25
1.821
TRP26
3.139
GLU59
2.747
ASN60
3.607
ASP61
3.709
GLY64
4.124
GLY65
3.148
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex. J Mol Biol. 2008 Oct 31;383(1):78-91. | ||||
REF 2 | Crystal structure of human osteoclast cathepsin K complex with E-64. Nat Struct Biol. 1997 Feb;4(2):109-11. | ||||
REF 3 | Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions. J Biol Chem. 2011 Mar 18;286(11):8988-98. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.